%0 Journal Article %1 Mall2006 %A Mall, Volker %A Heinen, Florian %A Siebel, Andrea %A Bertram, Christoph %A Hafkemeyer, Ulrich %A Wissel, J?rg %A Berweck, Steffen %A Haverkamp, Fritz %A Nass, G?nter %A D?derlein, Leo %A Breitbach-Faller, Nico %A Schulte-Mattler, Wilhelm %A Korinthenberg, Rudolf %D 2006 %J Dev Med Child Neurol %K Botulinum Toxin Type A; Cerebral Palsy; Child; Child, Preschool; Double-Blind Method; Female; Hip Joint; Humans; Knee Male; Muscle Spasticity; Neuromuscular Agents; Placebos; Treatment Outcome %N 1 %P 10--13 %R 10.1017/S0012162206000041 %T Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. %U http://dx.doi.org/10.1017/S0012162206000041 %V 48 %X Adductor spasticity in children with cerebral palsy (CP) impairs motor function and development. In a placebo-controlled, double-blind, randomized multicentre study, we evaluated the effects of botulinum toxin A(BTX-A) in 61 children (37 males, 24 females; mean age 6 years 1 month SD 3y 1mo) with CP (leg-dominated tetraparesis, n=39; tetraparesis, n=22; GMFCS level I, n=3; II, n=6; III, n=17; IV, n=29; V, n=6). Four weeks after treatment, a significant superiority of BTX-A was observed in the primary outcome measure (knee-knee distance 'fast catch', p=0.002), the Ashworth scale (p=0.001), and the Goal Attainment Scale (p=0.037).

@article{Mall2006, abstract = {Adductor spasticity in children with cerebral palsy (CP) impairs motor function and development. In a placebo-controlled, double-blind, randomized multicentre study, we evaluated the effects of botulinum toxin A(BTX-A) in 61 children (37 males, 24 females; mean age 6 years 1 month [SD 3y 1mo]) with CP (leg-dominated tetraparesis, n=39; tetraparesis, n=22; GMFCS level I, n=3; II, n=6; III, n=17; IV, n=29; V, n=6). Four weeks after treatment, a significant superiority of BTX-A was observed in the primary outcome measure (knee-knee distance 'fast catch', p=0.002), the Ashworth scale (p=0.001), and the Goal Attainment Scale (p=0.037).}, added-at = {2014-07-19T20:45:14.000+0200}, author = {Mall, Volker and Heinen, Florian and Siebel, Andrea and Bertram, Christoph and Hafkemeyer, Ulrich and Wissel, J?rg and Berweck, Steffen and Haverkamp, Fritz and Nass, G?nter and D?derlein, Leo and Breitbach-Faller, Nico and Schulte-Mattler, Wilhelm and Korinthenberg, Rudolf}, biburl = {https://www.bibsonomy.org/bibtex/2fd26cc61a2cf50579626e063ff93493e/ar0berts}, doi = {10.1017/S0012162206000041}, groups = {public}, interhash = {5d3f95f65969d23c7a41c7ffb39c4e1e}, intrahash = {fd26cc61a2cf50579626e063ff93493e}, journal = {Dev Med Child Neurol}, keywords = {Botulinum Toxin Type A; Cerebral Palsy; Child; Child, Preschool; Double-Blind Method; Female; Hip Joint; Humans; Knee Male; Muscle Spasticity; Neuromuscular Agents; Placebos; Treatment Outcome}, month = Jan, number = 1, pages = {10--13}, pii = {S0012162206000041}, pmid = {16359588}, timestamp = {2014-07-19T20:45:14.000+0200}, title = {Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study.}, url = {http://dx.doi.org/10.1017/S0012162206000041}, username = {ar0berts}, volume = 48, year = 2006 }